• Imec announces whole genome data analysis available in just a few hours

    Thursday October 1st 2020

  • Biotalys awarded €1.1 million VLAIO research grant

    Thursday October 1st 2020

  • Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial

    Wednesday September 30th 2020

  • Biocartis receives EUR 1.2 million grant for development of highly innovative Idylla™ GeneFusion Assay

    Wednesday September 30th 2020

  • BISC Global selected as top 10 bioinformatics company by CIO Applications

    Tuesday September 29th 2020

  • Celyad Oncology announces clinical trial collaboration to evaluate CYAD-101 with KEYTRUDA® (pembrolizumab) in patients with Microsatellite Stable mCRC

    Tuesday September 29th 2020

  • Jyseleca® (filgotinib) approved by European Commission for rheumatoid arthritis

    Friday September 25th 2020

  • Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis

    Friday September 25th 2020

  • Your news here?

  • Bioqube Ventures welcomes two seasoned professionals

    Friday September 25th 2020

  • Johnson & Johnson initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 vaccine candidate

    Thursday September 24th 2020

  • Camel-IDS enters next stage with name change to PRECIRIX® and IND approval for CAM-H2 Phase I/II study

    Tuesday September 22nd 2020


Strategic Partners